A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
With a robust healthcare network, renowned medical research centers, and innovative treatments, Ohio is a leading destination for a wide range of clinical trials. Institutions such as the Cleveland Clinic, Ohio State University Wexner Medical Center, University Hospitals Cleveland Medical Center, and Nationwide Children’s Hospital are at the forefront of these studies.
Why choose Ohio for clinical trials?
Ohio offers distinct advantages in the clinical research landscape. The state's diverse population provides a wide range of participants, enhancing the accuracy and relevance of research outcomes. Ohio is also recognized for its strong research environment, with a focus on medical innovation and pioneering studies in various fields.
By choosing to participate in a clinical trial in Ohio, participants contribute to vital medical research while benefiting from a well-established clinical trial infrastructure supported by top-tier healthcare institutions. This ensures they receive cutting-edge care and support throughout the process.
Common conditions studied in Ohio
In Ohio, clinical trials cover a wide range of medical conditions and diseases, reflecting the state's diverse healthcare research landscape.
Cancer
Ohio is home to leading cancer research centers like the Cleveland Clinic and Ohio State University Comprehensive Cancer Center, which conduct trials on various cancer types, including breast, lung, colorectal, and prostate cancers. These studies often focus on immunotherapies, targeted treatments, and novel drug combinations.
Oncology trials in Ohio are crucial due to the state’s significant cancer burden. Institutions like OSUCCC–James and the Cleveland Clinic are recognized for their commitment to groundbreaking research and patient care.
Neurological disorders
Institutions like the Cleveland Clinic and Ohio State University Wexner Medical Center are leaders in trials for neurological conditions, including Alzheimer’s disease, Parkinson’s disease, multiple sclerosis (MS), and stroke prevention. Research includes innovative therapies such as deep brain stimulation, new drug treatments, innovative diagnostics tools, and regenerative medicine.
Given the increasing prevalence of neurodegenerative diseases in Ohio’s aging population, these trials are vital for developing more effective treatments and improving the quality of life for patients.
Cardiovascular diseases
Heart disease is a major focus in Ohio's clinical trials, with cardiovascular studies looking into advanced treatments for conditions like heart failure, coronary artery disease, congenital heart disorders, hypertension, and arrhythmias. These trials often explore the use of new medications, medical devices, and surgical interventions.
Research centers like the Cleveland Clinic, Ohio State University Wexner Medical Center, and University Hospitals are conducting trials on innovative treatments such as gene therapies, advanced medical devices like pacemakers and stents, and novel drug therapies aimed at improving heart function and reducing mortality rates.
Autoimmune diseases
Conditions such as rheumatoid arthritis, lupus, inflammatory bowel disease, and Crohn's disease are commonly studied in Ohio. Leading institutions like the Cleveland Clinic, Ohio State University Wexner Medical Center, and University Hospitals are conducting trials on novel biologics, immunosuppressive therapies, targeted therapies, and immunomodulatory drugs designed to better manage disease symptoms and halt progression.
Diabetes and endocrine disorders
Ohio conducts numerous clinical trials on diabetes, focusing on better glucose control, insulin delivery systems, and new medications aimed at managing both Type 1 and Type 2 diabetes, as well as related endocrine disorders. Major research institutions here also explore conditions like diabetic neuropathy, obesity, thyroid disorders, and metabolic syndrome.
With high rates of diabetes and obesity in the state, these trials are crucial for addressing public health concerns.
Respiratory diseases
In Ohio, clinical trials for respiratory diseases focus on conditions such as asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and cystic fibrosis as these are prevalent in the state.
Prominent institutions like the Cleveland Clinic, Ohio State University Wexner Medical Center, and University Hospitals are leading trials on innovative treatments, including new inhalation therapies, biologics targeting specific inflammatory pathways, disease management strategies, and advanced drug delivery systems.
Local regulations and guidelines
Clinical trials in Ohio are regulated through a combination of federal, state, and institutional guidelines to ensure participant safety and ethical conduct. Federal regulations from the FDA oversee the approval of new drugs and medical devices, while Institutional Review Boards (IRBs) review and approve trials to protect participants' rights, privacy, and welfare.
At the state level, the Ohio Department of Health enforces regulations that include strict informed consent requirements, ensuring participants are fully informed about the risks and benefits of a trial. Additionally, Ohio's leading medical institutions, such as the Cleveland Clinic and Ohio State University Wexner Medical Center, follow their own rigorous protocols for patient care and data management, while complying with HIPAA standards to protect patient privacy.
Benefits of participating in clinical trials
Joining a clinical trial provides early access to cutting-edge treatments and therapies before they become widely available, which is the primary benefit. The benefits for participants in clinical trials also include exceptional care by leading healthcare professionals, with comprehensive monitoring and specialized support throughout the study.
Moreover, participating in clinical trials is vital for advancing medical research, which can lead to transformative breakthroughs in treatments. By taking part, individuals gain access to pioneering medical solutions and play a key role in scientific progress, ultimately improving future healthcare outcomes for others.
Interested in participating in clinical trials but worried about how long they might take? Check out our comprehensive guide for all the information you need to make an informed decision.
How to enroll in a clinical trial in Ohio
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify your trial: Use our intuitive search bar or filter options to locate clinical trials specific to requirements. This first step simplifies the process of finding relevant research studies tailored to your needs.
- Select your preferred location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore study details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the health profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.